HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corey Cutler Selected Research

Tacrolimus (Prograf)

12/2022GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial.
1/2020Long-Term Utilization Patterns of Topical Therapy and Clinical Outcomes of Oral Chronic Graft-versus-Host Disease.
1/2020Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.
1/2019Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
12/2017Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.
11/2017Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT.
1/2017Improved survival after acute graft-versus-host disease diagnosis in the modern era.
11/2016An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease.
4/2016The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial.
9/2015Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Corey Cutler Research Topics

Disease

55Graft vs Host Disease (Graft-Versus-Host Disease)
12/2022 - 09/2003
39Bronchiolitis Obliterans Syndrome
10/2022 - 04/2005
20Neoplasms (Cancer)
10/2021 - 09/2009
19Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2021 - 09/2003
18Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 09/2003
14Leukemia
12/2022 - 09/2009
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2021 - 09/2003
5Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2022 - 08/2012
4Infections
01/2021 - 04/2006
3Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
04/2022 - 07/2013
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020 - 10/2006
3Thrombotic Microangiopathies
11/2018 - 07/2005
2Injection Site Reaction
12/2022 - 11/2017
2Cytopenia
01/2021 - 12/2020
2Acute Kidney Injury (Acute Renal Failure)
01/2020 - 01/2019
2Viremia
10/2019 - 05/2010
2Body Weight (Weight, Body)
07/2016 - 01/2013
2Lymphoma (Lymphomas)
04/2016 - 09/2015
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2012 - 09/2006
2Iron Overload
06/2012 - 06/2011
2Mucositis
05/2005 - 05/2004
1Hypotension (Low Blood Pressure)
11/2022
1Hematuria
11/2022
1Epistaxis (Nosebleed)
11/2022
1Xerostomia
01/2021
1COVID-19
01/2021
1Cytokine Release Syndrome
01/2021
1Chromosome Aberrations (Chromosome Abnormalities)
01/2020
1Pain (Aches)
01/2020
1Pathologic Complete Response
01/2020
1Hemorrhagic Cystitis
10/2019
1Erythema
01/2019
1Sclerosis
01/2019
1Cytomegalovirus Infections (Inclusion Disease)
10/2018
1Bacterial Infections (Bacterial Infection)
08/2017
1Venous Thromboembolism
01/2017

Drug/Important Bio-Agent (IBA)

16Tacrolimus (Prograf)FDA LinkGeneric
12/2022 - 09/2003
16Sirolimus (Rapamycin)FDA Link
01/2021 - 09/2003
12Methotrexate (Mexate)FDA LinkGeneric
12/2022 - 09/2003
11SteroidsIBA
01/2022 - 08/2004
8Calcineurin InhibitorsIBA
11/2021 - 05/2004
6Busulfan (Busulfex)FDA Link
01/2020 - 06/2010
5VaccinesIBA
12/2022 - 09/2009
5fludarabineIBA
01/2020 - 06/2010
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2022 - 09/2009
4Interleukin-2 (IL2)IBA
01/2022 - 12/2011
4Biomarkers (Surrogate Marker)IBA
01/2019 - 06/2012
4AntigensIBA
03/2015 - 07/2006
4Rituximab (Mabthera)FDA Link
06/2013 - 07/2006
3ibrutinibIBA
12/2021 - 11/2014
3Biological ProductsIBA
10/2021 - 09/2009
3Adrenal Cortex Hormones (Corticosteroids)IBA
05/2021 - 09/2004
3Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2020 - 06/2013
3DNA (Deoxyribonucleic Acid)IBA
11/2012 - 01/2010
2belumosudilIBA
10/2022 - 12/2021
2Immunosuppressive Agents (Immunosuppressants)IBA
10/2022 - 08/2012
2IpilimumabIBA
10/2021 - 07/2016
2Natalizumab (Tysabri)FDA Link
05/2021 - 01/2021
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 - 11/2016
2Proteins (Proteins, Gene)FDA Link
07/2016 - 03/2015
2CytokinesIBA
03/2015 - 09/2013
2AntibodiesIBA
03/2015 - 04/2005
2Bortezomib (Velcade)FDA Link
09/2012 - 10/2009
2IronIBA
06/2012 - 06/2011
2Ferritins (Ferritin)IBA
06/2012 - 06/2011
2Monoclonal AntibodiesIBA
09/2009 - 09/2003
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2005 - 09/2003
1Prednisone (Sone)FDA LinkGeneric
11/2021
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
10/2021
1ProgesteroneFDA LinkGeneric
01/2021
1NivolumabIBA
11/2020
1EndoglinIBA
01/2020
1Melphalan (Alkeran)FDA LinkGeneric
01/2020
1FollistatinIBA
01/2020
1Alemtuzumab (Campath)FDA Link
01/2020
1vedolizumabIBA
12/2019
1Indicators and Reagents (Reagents)IBA
12/2019
1H-Y antibodyIBA
01/2019
1B-Cell Activating FactorIBA
01/2019
1CreatinineIBA
01/2019
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2018
1Valacyclovir (Valtrex)FDA LinkGeneric
10/2018
1FicolinsIBA
12/2017
1trans-crotonin (CTN)IBA
12/2017
1Anti-Bacterial Agents (Antibiotics)IBA
08/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017

Therapy/Procedure

50Hematopoietic Stem Cell Transplantation
11/2022 - 08/2004
38Therapeutics
11/2022 - 09/2004
35Transplantation
04/2022 - 09/2003
26Cell Transplantation
10/2022 - 10/2006
21Stem Cell Transplantation
12/2020 - 05/2004
6Homologous Transplantation
11/2020 - 10/2006
6Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2013 - 05/2004
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2014 - 10/2012
2Platelet Transfusion (Blood Platelet Transfusions)
01/2020 - 01/2019
2Drug Therapy (Chemotherapy)
09/2015 - 10/2006
1Donor Selection
01/2021
1Length of Stay
01/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021
1Immunomodulation
01/2018